Biotheranostics stock
WebJan 8, 2024 · Hologic, Inc. (. HOLX Quick Quote. HOLX - Free Report) recently announced its plans to acquire Biotheranostics, Inc., a privately held commercial-stage company providing molecular diagnostic tests ... WebBiotheranostics is a molecular diagnostics company that develops and provides diagnostic, prognostic, and predictive tests that helps physicians in the treatment of cancer patients. It offers CancerTYPE ID, a gene expression test for metastatic patients with diagnostic ambiguity, and Breast Cancer Index, a tool for breast cancer patients.
Biotheranostics stock
Did you know?
WebJan 6, 2024 · Biotheranostics is a privately-held company that sells molecular diagnostics tests for breast and metastatic cancers. Hologic said the company generated about $33 … WebAdaptive Biotechnologies (NASDAQ: ADPT) focuses on immuno-sequencing diagnostics, specifically in oncology. It studies and researches sequencing to profile T-Cell and B-Cell Receptors. It incorporates immuno-sequencing into clinical care for diagnosis, prognosis, and monitoring of cancer patients. The company was founded in 2009 and is based in ...
WebFeb 21, 2024 · This report contains market sizing and forecasts for this important area of molecular testing, including the following global market information: Global Molecular Cancer Diagnostics Market, 2024 ... Web(See HOLX stock analysis on TipRanks) Following the deal, Needham analyst Michael Matson said, “HOLX is a leader in the infectious disease testing market and we believe …
WebBiotheranostics, Inc. has been acquired by Hologic. Hologic is an innovative medical technology company whose purpose is to enable healthier lives everywhere, every day. … WebDec 11, 2024 · San Diego, CA, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Biotheranostics, Inc., announces the launch of its Not Another Minute campaign, revealing how Breast Cancer Index (BCI) is changing the game for early-stage, hormone receptor-positive (HR+) breast cancer patients. At the 42nd annual San Antonio Breast Cancer Symposium …
WebOct 29, 2024 · San Diego, CA, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Biotheranostics announces the publication of results from the IDEAL study in Clinical Cancer Research which reports novel findings of the Breast ...
WebFeb 23, 2024 · February 23, 2024 By Sean Whooley. Hologic (NSDQ: HOLX) announced that it completed its previously announced acquisition of Biotheranostics for $230 million. Marlborough, Mass.-based Hologic last ... grandview timeshares las vegas nvWebJan 5, 2024 · Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, announced today that it has agreed to acquire Biotheranostics, Inc., a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers, for approximately $230 million, subject to working capital and other customary closing … grandview title agency of bergen county llcWebJan 19, 2024 · Biotheranostics, Inc., is a leading healthcare provider in the oncology field assisting physicians in the treatment of cancer patients. ... The bank suspended its … grandview tn weather radarWebApr 1, 2024 · Stock quotes by finanzen.net Two crossed lines that form an 'X'. ... Biotheranostics, Inc., is a leading healthcare provider in the oncology field assisting physicians in the treatment of cancer ... grandview tn property taxWebNot Registered? Click here to start the process.. Loading chinese takeaway south elmsallWebJan 8, 2024 · Hologic, Inc. HOLX recently announced its plans to acquire Biotheranostics, Inc., a privately held commercial-stage company providing molecular diagnostic tests for breast and metastatic cancers ... grandview tn to athens tnWebJan 19, 2024 · Contact Data Lisa Whitmyer Biotheranostics, Inc. 216-513-7808 [email protected] grandview tn to chattanooga tn